Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy
- 16 January 2020
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 382 (3) , 294-296
Abstract
Extracorporeal photopheresis has been an effective treatment for graft-versus-host disease. In this case, it was used to treat a patient with severe autoimmune colitis induced by checkpoint-inhibitor therapy for melanoma. The extracorporeal photopheresis resulted in an increased number of immunoregulatory natural killer cells.Keywords
This publication has 5 references indexed in Scilit:
- Shaping of CD56bri Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal PhotopheresisFrontiers in Immunology, 2019
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and TherapyNew England Journal of Medicine, 2017
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaNew England Journal of Medicine, 2017
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaNew England Journal of Medicine, 2015
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated MelanomaNew England Journal of Medicine, 2015